Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
51.75
-1.15 (-2.17%)
May 11, 2026, 3:59 PM HKT

HKG:6609 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
408.29277.9232.34183.0390.09
Revenue Growth (YoY)
46.92%19.61%26.94%103.17%518.66%
Cost of Revenue
136.12104.2480.5559.1535.14
Gross Profit
272.17173.66151.79123.8854.95
Selling, General & Admin
187.12137.81153.88167.99135.01
Research & Development
40.7658.94123.83153.6976.31
Other Operating Expenses
0.0110.260.951.823.21
Operating Expenses
227.89207278.66323.5214.53
Operating Income
44.27-33.34-126.87-199.62-159.58
Interest Expense
-2.06-1.75-2.16-2.15-2.36
Interest & Investment Income
6.248.7711.215.145.5
Earnings From Equity Investments
----34.8-
Currency Exchange Gain (Loss)
-2.021.171.48.3-22.28
Other Non Operating Income (Expenses)
16.178.7911.2111.88-23.02
EBT Excluding Unusual Items
62.6-16.36-105.22-201.25-201.74
Gain (Loss) on Sale of Investments
27.264.370.93-3.84
Gain (Loss) on Sale of Assets
-3.46-1.37--
Pretax Income
86.41-11.99-102.92-201.25-197.91
Income Tax Expense
3.071.63-8.91-0.87-
Earnings From Continuing Operations
83.34-13.62-94.01-200.38-197.91
Minority Interest in Earnings
----3.68
Net Income
83.34-13.62-94.01-200.38-194.23
Net Income to Common
83.34-13.62-94.01-200.38-194.23
Shares Outstanding (Basic)
3838383833
Shares Outstanding (Diluted)
3838383833
Shares Change (YoY)
0.47%-0.81%-0.51%14.60%52.84%
EPS (Basic)
2.21-0.36-2.47-5.24-5.82
EPS (Diluted)
2.20-0.36-2.47-5.24-5.82
Free Cash Flow
142.55-7.27-92.98-303.28-258.69
Free Cash Flow Per Share
3.76-0.19-2.44-7.92-7.75
Gross Margin
66.66%62.49%65.33%67.68%60.99%
Operating Margin
10.84%-12.00%-54.60%-109.06%-177.13%
Profit Margin
20.41%-4.90%-40.46%-109.48%-215.59%
Free Cash Flow Margin
34.91%-2.62%-40.02%-165.70%-287.14%
EBITDA
64.43-9.87-102.57-173.68-152.15
EBITDA Margin
15.78%-3.55%-44.14%-94.89%-168.88%
D&A For EBITDA
20.1623.4724.325.947.43
EBIT
44.27-33.34-126.87-199.62-159.58
EBIT Margin
10.84%-12.00%-54.60%-109.06%-177.13%
Effective Tax Rate
3.56%----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.